MidFirst Bank’s Bio-Techne TECH Stock Holding History

MidFirst Bank’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.31K	Hold	61	–	–	﹤0.01%	602
2026 Q1	$3.19K	Sell	61 -3,734	-98%	-$224K	﹤0.01%	626
2025 Q4	$3.47K	Buy	+3,795	New	+$231K	﹤0.01%	648

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MidFirst Bank's TECH Position: Q2 2026 in Review

MidFirst Bank held its Bio-Techne (TECH) position steady in Q2 2026 at 61 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

MidFirst Bank first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 442 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

MidFirst Bank held 61 shares of Bio-Techne worth $4.31K as of Q2 2026.
MidFirst Bank left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #602 holding.
MidFirst Bank first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
442 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.